BLOCKING malaria transmission by targeting the malaria parasite inside mosquitoes so that it is no longer transmitted by the mosquito parasites before it can infect humans . A rec ...

Monoclonal antibodies against SARS-CoV-2 were considered a promising approach for the prevention and therapy of coronavirus infections. However, the ongoing evolution of the virus regularly ...

A groundbreaking study from the University of Southampton reveals that engineering antibodies to be more rigid significantly enhances their ability to activate immune cells, potentially offering a ...

Engineering an antibody against flu with sticky staying power Aerosol treatment adheres to lung lining, blocks infection in mice Date: May 8, 2025 Source: Ohio State University Summary: Scientists ...

antibody positive, the release noted. It will be supplied as a single-dose vial per carton for IV injection. Today’s approval, as well as the FDA Priority Review designation announced in ...

An antibody from an Ebola survivor may be the key to fighting the virus more efficiently. The mAb 3A6 antibody binds to a hidden part of Ebola’s structure, stopping infection in its tracks, even at ...

Mapping an antibody’s epitope, where it binds a target, can now be done in three dimensions, which optimizes the selection of application-specific antibodies When using antibodies in research or ...

Even with significant expansion in the global market for antibodies used in clinical care and research, scientists recognize that there is still untapped potential for finding new antibodies.

(Bambusa), a clinical-stage biotechnology company developing novel biologics for inflammatory and immunological diseases, today announced the initiation of dosing in healthy volunteers (HV) in its ...

Monoclonal antibodies have specificity for a particular antigen (target of antibodies), but polyclonal ones are not specific to any antigen. Recombinant ones are monoclonal, and here are the key ...

Bispecific antibodies seem to be all the rage at the minute. Their ability to deliver targeted therapeutics to patients with a two-in-one approach by simultaneously binding to two different antigens ...

Monoclonal antibodies (mAbs) are manufactured proteins that behave similarly to antibodies found naturally in the body. Researchers initially developed them for treating certain cancers but have ...